Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

112

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
05/11/26	€0.1532	-0.91%	69,966
04/11/26	€0.1546	+7.81%	201,459
03/11/26	€0.1434	-8.08%	457,067
02/11/26	€0.1560	-1.27%	201,237
30/10/26	€0.1580	-1.13%	349,232

Real-time Euronext Paris

More quotes

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Klea Holding

Company calendar

Real-time Euronext Paris 13:10:52 05/11/2026 +03			5-day change	1st Jan Change
0.1532 ^EUR	-0.91%		-4.13%	-30.05%

10-21	Klea Holding SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
10-08	Klea Holding Sa Confirms Earnings Guidance for the Year 2026	CI

Market Cap	47.46M 53.26M 43.52M 39.55M 74.36M 5.03B 76.06M 520M 209M 2.66B 200M 196M 8.44B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	47.59M 53.4M 43.64M 39.66M 74.55M 5.05B 76.26M 522M 209M 2.67B 200M 196M 8.46B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Euronext Paris	ALKLH	Real-time
Deutsche Boerse AG	7V91	Delayed
Börse Stuttgart	7V91	Delayed
Boerse Muenchen	7V91	Real-time
Tradegate	7V91	Real-time

10-21	Klea Holding SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
10-08	Klea Holding Sa Confirms Earnings Guidance for the Year 2026	CI
10-08	Klea Holding Sa Reports Unaudited Consolidated Sales Results for the Third Quarter of 2026	CI
09-10	Klea Pharmaceuticals Receives First Order from Alphamed and Expands Distribution in the Middle East	CI
09-09	Klea Holding Launches Wellness Brand in Dubai	MT
09-08	Klea Holding's Smart Health Unit to Open First Digital Medical Center in Saudi Arabia in Few Weeks	MT
09-07	Klea Holding Provides Update on the Opening of the 1St Digital Medical Centre in Riyadh	CI
08-11	Klea Holding SA Reports Unaudited Consolidated Sales Results for the first half of 2026	CI
07-29	EQT to sell Quantios to Vista Equity Partners	FW
07-15	Klea Holding targets improved profitability in the second half
06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
06-11	Klea Holding announces the launch of its new subsidiary

Klea Holding Stock

Stocks

ALKLH

FR0013481835

Healthcare Facilities & Services

Valuation: Klea Holding

Chart: Klea Holding

Latest news: Klea Holding

Analysts' recommendations: Klea Holding

Press Releases: Klea Holding

News in other languages: Klea Holding

Quotes and Performance

Price Extremes

Managers and Directors: Klea Holding

Latest insider transactions

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

10-08	Klea : confirms its gradual rebound in Q3 2026 and targets revenue growth in Q4 2026	PU
10-08	Klea Holding : Klea Holding confirms its gradual rebound in Q3 2026 and targets revenue growth in Q4 2026	AT
09-28	Klea : Still profitable in H1 2026, Klea Holding invests in its future growth drivers	PU
09-28	Klea Holding : Still profitable in H1 2026, Klea Holding invests in its future growth drivers	AT
09-10	Klea : Pharmaceuticals secures its first order and reaffirms its ambitions for strong and profitable growth	PU

10-30	Klea : DeclarationDirigeants
10-30	Klea : DeclarationDirigeants
10-30	Klea : DeclarationDirigeants
10-30	Klea : DeclarationDirigeants
10-30	Klea : DeclarationDirigeants

1 day	-0.91%
1 week	-4.13%
Current month	-3.04%
1 month	+12.98%
3 months	-2.42%
6 months	-16.56%
Current year	-30.05%

1 week	0.14	0.16
1 month	0.1	0.16
Current year	0.1	0.25
1 year	0.1	0.26
3 years	0.1	0.34
5 years	0.08	0.59
10 years	0.08	149.6

Manager	Title	Age	Since
Raphael Smila CEO	Chief Executive Officer	-	10/06/2025
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-

Date	Insider	Type	Quantity	% Market Cap.
7/17/26 A	Raphael Smila	Buy	103,000	0.0335%
7/17/26 A	Raphael Smila	Buy	103,000	0.0335%
7/16/26 A	Raphael Smila	Buy	87,000	0.0283%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLEA HOLDING	-0.91%	-4.13%	-34.25%	-49.47%	53.26M
CVS HEALTH CORPORATION	-12.53%	-11.11%	+2.41%	+13.82%	102B
HCA HEALTHCARE, INC.	+10.34%	+10.25%	+8.27%	+121.24%	107B
NATERA, INC.	+0.62%	-7.87%	+99.05%	+814.90%	56.36B
FRESENIUS SE & CO. KGAA	+9.04%	+1.44%	-3.13%	+85.70%	32.48B
LABCORP HOLDINGS INC.	+3.92%	+2.09%	+45.76%	+74.95%	29.86B
QUEST DIAGNOSTICS INCORPORATED	+3.49%	+4.10%	+43.62%	+90.93%	28.13B
TENET HEALTHCARE CORPORATION	+9.58%	+8.85%	+40.69%	+432.14%	23.26B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+1.45%	-2.26%	-18.79%	-13.75%	19.9B
IHH HEALTHCARE	-0.77%	-1.66%	-6.76%	+28.45%	16.92B
Average	+2.42%	+0.43%	+17.69%	+159.89%	41.59B
Weighted average by Cap.	+1.45%	-0.33%	+23.22%	+187.82%

	2024	2025
Net sales	17.26M 19.37M 15.83M 14.38M 27.04M 1.83B 27.66M 189M 75.84M 969M 72.7M 71.15M 3.07B	22.17M 24.87M 20.33M 18.47M 34.73M 2.35B 35.52M 243M 97.4M 1.24B 93.37M 91.37M 3.94B
Net income	1.4M 1.58M 1.29M 1.17M 2.2M 149M 2.25M 15.4M 6.17M 78.87M 5.92M 5.79M 250M	2.28M 2.56M 2.09M 1.9M 3.57M 242M 3.66M 25M 10.02M 128M 9.61M 9.4M 406M
Net Debt	2.58M 2.89M 2.36M 2.15M 4.03M 273M 4.13M 28.22M 11.31M 145M 10.85M 10.61M 458M	125K 140K 115K 104K 196K 13.26M 200K 1.37M 549K 7.02M 527K 515K 22.23M